openPR Logo
Press release

Cancer Diagnostics Market Forecast to 2025 | Siemens Healthineers, Hologic, Inc. , BD, Becton Dickinson, GE Healthcare, Thermo Fisher Scientific, Roche, Illumina, Abbott, QIAGEN

10-03-2018 04:20 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Cancer Diagnostics Market

Cancer Diagnostics Market

Cancer diagnostics market report comprises of data that can be quite essential when it comes to dominating the market or making a mark in the market as a new emergent. The objective of Cancer diagnostics market report is to provide a detailed analysis of industry and its impact based on applications and on different geographical regions, strategically analyses the growth trends, future prospects. The market research report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2025. Cancer diagnostics market report also delivers lists of the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the Industry.

Global Cancer Diagnostics Market is expected to reach USD 40.10 billion by 2024 from USD 16.55 billion, at a CAGR of 11.7% in the forecast period.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

Forecasting Regional and Global Analysis on Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma) And Geography.

Key Points:

GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with

· Siemens Healthcare GmbH

· Hologic, Inc,

· Becton, Dickinson & Company.

Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as Roche Diagnostics, Abbott Laboratories, Inc. Qiagen.

¨ Next Generation Sequencing (NGS) market is growing with the highest CAGR.

¨ Globally biopsy is driving the market with highest market share.

¨ Magnetic Resonance Imaging (MRI) is dominating the cancer diagnostics imaging market.


The major factors driving the growth of Cancer Diagnostics Market are the growing with aging population worldwide, government initiatives for funding, and awareness about cancer. These factors increase the demand for cancer diagnostic products. On the other hand, stringent regulations imposed by international and local authorities and shortage of skilled and trained professionals may hinder the growth of the market.

The major factors driving the growth of this market are the growing ageing population worldwide, government initiatives for funding and awareness about cancer. These factors increase the demand for cancer diagnostic products. On the other hand, stringent regulations imposed by international and local authorities and shortage of skilled and trained professionals may hinder the growth of the market.


For TOC or Buy Full Report, Visit: https://databridgemarketresearch.com/toc/?dbmr=global-cancer-diagnostics-market


Market Segmentation: Cancer Diagnostics Market
· The global cancer diagnostics market is segmented on the basis of technology, application, and geography.

· The global cancer diagnostics market is segmented into two types,

• Platform based
• Instrument based

· In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.

· Cancer diagnostics platform based market is segmented into

• Polymerase chain reaction (PCR)
• In situ hybridization (ISH)
• Immunohisto chemistry (IHC)
• Next generation sequencing (NGS)
• DNA microarrays
• Flow cytometry and others

· Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography- computed tomography (PET-CT), mammography, and ultrasound.

· On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Key Drivers:

Some of the major factors driving the market for cancer diagnostics market are growing ageing population worldwide, government initiatives for funding and awareness about cancer. These factors increase the demand for cancer diagnostics products. Increasing prevalence of cancer, key players focusing are on strategic decisions and technological advancements are the major factors driving the growth of the cancer diagnostics market.

¨ Stringent regulations imposed by the international and local authorities and shortage of the skilled and trained professionals are the factors which may hinder the growth of this market.

¨ Many companies are increasingly focusing on Next Generation Sequencing (NGS) and biopsy products in order to strengthen their product portfolios in the cancer diagnostics market.

¨ Increasing demand for Magnetic Resonance Imaging (MRI) and Next Generation Sequencing (NGS) will drive the market in future.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization or Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Diagnostics Market Forecast to 2025 | Siemens Healthineers, Hologic, Inc. , BD, Becton Dickinson, GE Healthcare, Thermo Fisher Scientific, Roche, Illumina, Abbott, QIAGEN here

News-ID: 1278022 • Views: 313

More Releases from Data Bridge Market Research

Cell Based Assays Market to Set Phenomenal Growth By 2026 | Lonza, Miltenyi Biot …
Cell Based Assays Market Figures is now released by Data Bridge Market Research. Cell Based Assays Market report presents a complete assessment of covering future trend, Latest Trend, current growth factors, facts, and industry validated market data forecast till 2026. The report provides an in-depth analysis of the latest trends, business scenario, size and share of Major Competitors such as Aurelia Bioscience Ltd, BD, BioAgilytix Labs, BioVision Inc., Cell Signaling
Fish Protein Hydrosylate Market Emerging Trends, Share and Forecast with Top Ven …
Fish Protein Hydrosylate Market Figures is now released by Data Bridge Market Research. Fish Protein Hydrosylate Market report presents a complete assessment of covering future trend, Latest Trend, current growth factors, facts, and industry validated market data forecast till 2026. The report provides an in-depth analysis of the latest trends, business scenario, size and share of Major Competitors such as Diana Group , SOPROPECHE , TripleNine Group, Scanbio, New Alliance
Data Center Power Market Analysis, Segment and Forecasts by Top Company Toshiba …
Data Center Power Market Figures is now released by Data Bridge Market Research. Data Center Power Market report presents a complete assessment of covering future trend, Latest Trend, current growth factors, facts, and industry validated market data forecast till 2026. The report provides an in-depth analysis of the latest trends, business scenario, size and share of Major Competitors such as Shenzhen Kstar Science&Technology Co.,Ltd.; Hitachi Hi-Rel Power Electronics Pvt. Ltd.;
Multivitamin Tablets Market SWOT Analysis with Top Key Players | 21ST Century He …
Multivitamin Tablets Market Figures is now released by Data Bridge Market Research. Multivitamin Tablets Market report presents a complete assessment of covering future trend, Latest Trend, current growth factors, facts, and industry validated market data forecast till 2026. The report provides an in-depth analysis of the latest trends, business scenario, size and share of Major Competitors such as SAILLON PHARMA; HEALTHY LIFE PHARMA PVT. LTD.; HealthKart.com; Truebasics.com; 21ST Century HealthCare,

All 5 Releases


More Releases for Cancer

Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and